Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
BMJ Case Reports
|
April 15, 2018
Anti-TNF therapy-induced lupus erythematosus-like syndrome in a patient treated with adalimumab for cutaneous psoriasis
Julie E Stein, Jeffrey Patterson-Fortin, Benjamin E Bodnar
Journal of Cutaneous Pathology
|
April 21, 2022
Immune cell subsets in interface cutaneous immune-related adverse events associated with anti-PD-1 therapy resemble acute graft versus host disease more than lichen planus
Guillermo E Almodovar Cruz, Genevieve Kaunitz, Julie E Stein, et al.
Science Immunology
|
October 13, 2019
Interleukin-36γ-producing macrophages drive IL-17-mediated fibrosis
Sven D Sommerfeld, Christopher Cherry, Remi M Schwab, et al.
Cancer Immunology, Immunotherapy : CII
|
October 30, 2020
Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas
Farah Succaria, Pia Kvistborg, Julie E Stein, et al.
The Pediatric Infectious Disease Journal
|
November 12, 2020
Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report
Jeanette T Beaudry, Barbara Dietrick, Dawn B Lammert, et al.
JAMA Oncology
|
July 19, 2019
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis
Steve Lu, Julie E Stein, David L Rimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
Julie E Stein, Evan J Lipson, Tricia R Cottrell, et al.
European Urology Oncology
|
May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma
Michael A Gorin, Hiten D Patel, Steven P Rowe, et al.
Journal for Immunotherapy of Cancer
|
June 4, 2021
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Robert L Ferris, William C Spanos, Rom Leidner, et al.
Cancer Immunology Research
|
August 26, 2021
Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery
Nicolas A Giraldo, Sneha Berry, Etienne Becht, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
BMJ Case Reports
|
April 15, 2018
Anti-TNF therapy-induced lupus erythematosus-like syndrome in a patient treated with adalimumab for cutaneous psoriasis
Julie E Stein, Jeffrey Patterson-Fortin, Benjamin E Bodnar
Journal of Cutaneous Pathology
|
April 21, 2022
Immune cell subsets in interface cutaneous immune-related adverse events associated with anti-PD-1 therapy resemble acute graft versus host disease more than lichen planus
Guillermo E Almodovar Cruz, Genevieve Kaunitz, Julie E Stein, et al.
Science Immunology
|
October 13, 2019
Interleukin-36γ-producing macrophages drive IL-17-mediated fibrosis
Sven D Sommerfeld, Christopher Cherry, Remi M Schwab, et al.
Cancer Immunology, Immunotherapy : CII
|
October 30, 2020
Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas
Farah Succaria, Pia Kvistborg, Julie E Stein, et al.
The Pediatric Infectious Disease Journal
|
November 12, 2020
Fatal SARS-CoV-2 Inflammatory Syndrome and Myocarditis in an Adolescent: A Case Report
Jeanette T Beaudry, Barbara Dietrick, Dawn B Lammert, et al.
JAMA Oncology
|
July 19, 2019
Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade: A Systematic Review and Meta-analysis
Steve Lu, Julie E Stein, David L Rimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
Julie E Stein, Evan J Lipson, Tricia R Cottrell, et al.
European Urology Oncology
|
May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell Carcinoma
Michael A Gorin, Hiten D Patel, Steven P Rowe, et al.
Journal for Immunotherapy of Cancer
|
June 4, 2021
Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial
Robert L Ferris, William C Spanos, Rom Leidner, et al.
Cancer Immunology Research
|
August 26, 2021
Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery
Nicolas A Giraldo, Sneha Berry, Etienne Becht, et al.
Page
of 2